Unprecedented Iraqi medical innovation that contributes to protecting patients with asthma.
Date:
18/12/2025
Unprecedented Iraqi medical innovation that contributes to protecting patients with asthma.
The Cultural Attache Celebrates an Unprecedented Iraqi Medical Innovation that Contributes to Protecting Asthma Patients Worldwide
The Cultural Attache is honored to announce that Dr. Saif Saad Fakhr al-Din, a biomedical engineering specialist, Indian Council for Cultural Relations (ICCR) fellow, and faculty member at the University of Mosul/College of Dentistry, has been granted a patent by the Patent Office – Government of India, for a pioneering medical innovation entitled:
“AN INNOVATIVE ASTHMA ATTACK PREDICTION AND MONITORING DEVICE”
This patent was granted under the provisions of the Indian Patents Act of 1970, with patent number 575875, for a period of twenty (20) years, effective September 14, 2023.
This innovation is the first of its kind globally in the field of monitoring asthma patients of all age groups, including children and schoolchildren. It contributes to protecting them from sudden asthma attacks through an advanced smart system based on early prediction and rapid response.
The device is easy to wear around the neck and uses a battery that lasts up to three days. It is also easy to use and highly flexible, operating efficiently even during movement or charging. It utilizes artificial intelligence technologies to monitor the patient s health status, with the ability to send automatic and immediate alerts to the hospital in emergency situations, ensuring rapid and effective medical intervention.
This device addresses the fundamental limitations of traditional devices in terms of size and practicality. It relies on an advanced smart algorithm supported by a set of sensors to detect coughing through sound and movement, in addition to monitoring heart rate, and incorporates a GSM module to send instant alerts to the patient and healthcare providers when needed. The invention underwent a rigorous series of scientific and technical tests under the supervision of a select group of expert specialists from India, given its direct impact on human health and its unprecedented nature. The evaluation and approval process took 28 months. The results of the practical verification, conducted on 100 volunteers, both asthmatic and non-asthmatic, demonstrated an accuracy of 98% in predicting the exacerbation of asthma attacks, making it an effective and vital tool for innovative disease management.
This innovation has also led to the publication of several scientific papers in reputable journals indexed in the Clarivate and Scopus (Q1) databases, reflecting the scientific and practical value of the research and showcasing the excellence of the Iraqi researcher at the international level and his ability to deliver groundbreaking innovations that contribute to the development of biomedical technologies and serve human health.
|